Results 21 to 30 of about 32,279 (194)
Principles of medullary thyroid cancer staging according to AJCC TNM 8th edition
Acta Medica Leopoliensia, 2021 Aim. The research aims at analyzing the main changes in classification of medullary thyroid cancer and outlining the principles of staging according to modern studies. Material and Methods.
O.R Duda, R.R. Slipetsky, N.I. Bojko
doaj +1 more source
Diagnosis of medullary thyroid cancer [PDF]
F1000 Medicine Reports, 2009 Medullary thyroid cancer (MTC) accounts for 5-10% of all thyroid cancers. The majority of medullary thyroid cancers are sporadic, but 25% of cases are inherited as a result of germline mutations in the RET proto-oncogene. In sporadic cases MTC presents as a thyroid nodule discovered at palpation or at thyroid ultrasonography, and is indistinguishable ...
Marchisotta, Stefania, Pacini, Furio
openaire +2 more sources
Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
Сибирский онкологический журнал, 2022 Background. Coronavirus disease 2019 (COVID-19) is a pandemic of the new millennium. COVID-19 can cause both pulmonary and systemic infammation, and can rapidly progress to multiple organ failure. Data on the relationship between COVID-19 and the thyroid
E. V. Ryabchenko
doaj +1 more source
Current Oncology, 2022 Selpercatinib, a RET kinase inhibitor, is an effective treatment for patients with medullary thyroid cancer with RET mutations. In this paper, we present the case of a 62-year-old man with ectopic Cushing’s syndrome due to medullary thyroid cancer who ...
Oskar Ragnarsson +2 more
doaj +1 more source
Frontiers in Endocrinology, 2021 BackgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic. The majority of medullary thyroid cancers present as a thyroid nodule.
Livia Sira +7 more
doaj +1 more source
Cabozantinib in Progressive Medullary Thyroid Cancer [PDF]
Journal of Clinical Oncology, 2013 Purpose Cabozantinib, a tyrosine kinase inhibitor (TKI) of hepatocyte growth factor receptor (MET), vascular endothelial growth factor receptor 2, and rearranged during transfection (RET), demonstrated clinical activity in patients with medullary thyroid cancer (MTC) in phase I.
ELISEI, ROSSELLA +18 more
openaire +6 more sources
Breast metastasis from medullary thyroid carcinoma: a report of a case
Surgical Case Reports, 2021 Background Metastasis to the breast is rare. We herein report a patient with metastatic medullary thyroid carcinoma to the breast for whom measuring the calcitonin level was an important clue to the correct diagnosis.
Yoko Omi +6 more
doaj +1 more source
Ukrainian Scientific Medical Youth Journal, 2021 the aim of the stydy was to analyze the detectability of medullary thyroid metastases in patients at treatment and diagnostic stages, to investigate the applicability of serum calcitonin level as predictor of possible presence of medullary thyroid ...
Volodymyr Palamarchuk +6 more
doaj +1 more source
BJS (British Journal of Surgery), EarlyView., 2020 This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek +18 more
wiley +1 more source
The Oncologist, EarlyView., 2021 Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth +10 more
wiley +1 more source